PubMed

Possible Implications of MCAM Expression in Metastasis and Non-Metastatic of Primary Uveal Melanoma Patients.

Beutel J, Wegner J, Wegner R, Ziemssen F, Nassar K, Rohrbach JM, Hilgers RD, Lüke M, Grisanti S.

Curr Eye Res. 2009 Nov;34(11):1004-9.PMID: 19958117 [PubMed - in process]

Tachyphylaxis and bevacizumab.

Ziemssen F, Neuhann IM, Voelker M.

Ophthalmology. 2009 Aug;116(8):1591-2; author reply 1592-3. No abstract available. PMID: 19651319 [PubMed - indexed for MEDLINE]Related articles

Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?

Biester S, Ziemssen F, Ulrich Bartz-Schmidt K, Gelisken F.

Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1575-7. Epub 2009 Jul 7. No abstract available. PMID: 19582472 [PubMed - indexed for MEDLINE]Related articles

Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Ziemssen F, Grisanti S, Bartz-Schmidt KU, Spitzer MS.

Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002. Review.PMID: 19476398 [PubMed - indexed for MEDLINE]Related articles

Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.

Mansour AM, Arevalo JF, Ziemssen F, Mehio-Sibai A, Mackensen F, Adan A, Chan WM, Ness T, Banker AS, Dodwell D, Chau Tran TH, Fardeau C, Lehoang P, Mahendradas P, Berrocal M, Tabbarah Z, Hrisomalos N, Hrisomalos F, Al-Salem K, Guthoff R.

Am J Ophthalmol. 2009 Aug;148(2):310-316.e2. Epub 2009 May 9.PMID: 19427992 [PubMed - indexed for MEDLINE]Related articles

[Intravitreal injections of medications in Germany. Contract situation and legal conditions]

Ziemssen F, Wiedemann P, Kampik A, Holz F, Bartz-Schmidt KU.

Ophthalmologe. 2009 May;106(5):465-70. German. PMID: 19408003 [PubMed - indexed for MEDLINE]Related articles

Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt KU, Gelisken F.

Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):745-54. Epub 2009 Feb 12.PMID: 19214552 [PubMed - indexed for MEDLINE]Related articles

[Macular translocation - a therapeutic approach for neovascular macular degeneration in the era of anti-VEGF therapy?]

Ziemssen F, Gelisken F.

Klin Monbl Augenheilkd. 2009 Jan;226(1):31-7. Epub 2009 Jan 27. Review. German. PMID: 19173161 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results.

Beutel J, Ziemssen F, Lüke M, Partsch M, Bartz-Schmidt KU; The Bevacizumab Study Group, Gelisken F.

Int Ophthalmol. 2008 Dec 20. [Epub ahead of print]PMID: 19099203 [PubMed - as supplied by publisher]Related articles

[Chances and risks of anti-VEGF therapy]

Ziemssen F, Heiduschka P, Peters S, Grisanti S, Schraermeyer U.

Klin Monbl Augenheilkd. 2008 Sep;225(9):770-8. Review. German. PMID: 18759208 [PubMed - indexed for MEDLINE]Related articles

Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.

Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X; Tübingen Bevacizumab Study Group, Grisanti S.

Ophthalmology. 2008 Oct;115(10):1750-5, 1755.e1. Epub 2008 Aug 16.PMID: 18708261 [PubMed - indexed for MEDLINE]Related articles

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion.

Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, Szurman P.

Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):27-33. Epub 2008 Aug 12.PMID: 18696094 [PubMed - indexed for MEDLINE]Related articles

Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.

Ulmer A, Beutel J, Süsskind D, Hilgers RD, Ziemssen F, Lüke M, Röcken M, Rohrbach M, Fierlbeck G, Bartz-Schmidt KU, Grisanti S.

Clin Cancer Res. 2008 Jul 15;14(14):4469-74.PMID: 18628461 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab in inflammatory ocular neovascularization.

Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M.

Am J Ophthalmol. 2008 Sep;146(3):410-416. Epub 2008 Jul 10.PMID: 18619571 [PubMed - indexed for MEDLINE]Related articles

Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study.

Leitritz M, Gelisken F, Inhoffen W, Voelker M, Ziemssen F.

Eye (Lond). 2008 Dec;22(12):1504-7. Epub 2008 Jun 6.PMID: 18535608 [PubMed - indexed for MEDLINE]Related articles

Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.

Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group, Ziemssen T.

Int Ophthalmol. 2009 Aug;29(4):213-24. Epub 2008 Apr 17.PMID: 18418553 [PubMed - indexed for MEDLINE]Related articles

Treatment of age-related macular degeneration: focus on ranibizumab.

Spitzer MS, Ziemssen F, Bartz-Schmidt KU, Gelisken F, Szurman P.

Clin Ophthalmol. 2008 Mar;2(1):1-14.PMID: 19668384 [PubMed - in process]Related articlesFree article

[Intravitreal injection. Monitoring to avoid postoperative complications]

Meyer CH, Ziemssen F, Heimann H.

Ophthalmologe. 2008 Feb;105(2):143-55, 157. Review. German. PMID: 18256842 [PubMed - indexed for MEDLINE]Related articles

[Postoperative antibiotics after intravitreal injection?]

Ziemssen F, Dietz K, Bartz-Schmidt KU.

Ophthalmologe. 2008 Feb;105(2):180-1; author reply 181-2. German. No abstract available. PMID: 18256840 [PubMed - indexed for MEDLINE]Related articles

Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.

Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W.

Eye (Lond). 2009 Mar;23(3):694-702. Epub 2008 Feb 1.PMID: 18239678 [PubMed - in process]Related articles

Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.

Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P.

J Cataract Refract Surg. 2008 Jan;34(1):70-5.PMID: 18165084 [PubMed - indexed for MEDLINE]Related articles

Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).

Ziemssen F, Lüke M, Bartz-Schmidt KU, Gelisken F.

Graefes Arch Clin Exp Ophthalmol. 2008 May;246(5):653-9. Epub 2007 Dec 11.PMID: 18071731 [PubMed - indexed for MEDLINE]Related articles

Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

Ziemssen F, Heiduschka P, Schraermeyer U; Tübingen Bevacizumab Study Group.

Retina. 2007 Oct;27(8):1154-6; author reply 1156-8. No abstract available. PMID: 18040264 [PubMed - indexed for MEDLINE]Related articles

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P; Tübingen Bevacizumab Study Group.

Acta Ophthalmol. 2008 May;86(3):322-8. Epub 2007 Nov 8.PMID: 17995975 [PubMed - indexed for MEDLINE]Related articles

Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.

Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, Boyd SR, Joussen AM, Ziemssen F, Hykin PG, Moss SE.

Cytokine. 2007 Nov;40(2):144-50. Epub 2007 Oct 23.PMID: 17959386 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab: off-label use in ophthalmology.

Grisanti S, Ziemssen F.

Indian J Ophthalmol. 2007 Nov-Dec;55(6):417-20. Review.PMID: 17951896 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.

Ziemssen F, Lüke M, Messias A, Beutel J, Tatar O, Zrenner E, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group.

Int Ophthalmol. 2008 Apr;28(2):101-9. Epub 2007 Jul 20.PMID: 17634860 [PubMed - indexed for MEDLINE]Related articles

Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy.

Ziemssen F, Voelker M, Inhoffen W, Bartz-Schmidt KU, Gelisken F.

Eye (Lond). 2007 Aug;21(8):1125-6. Epub 2007 Jun 1. No abstract available. PMID: 17545966 [PubMed - indexed for MEDLINE]Related articles

Penetration of bevacizumab through the retina after intravitreal injection in the monkey.

Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U; Tübingen Bevacizumab Study Group.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2814-23.PMID: 17525217 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreous bevacizumab and blood pressure: does 'safe' mean 'safe enough'?

Ziemssen F, Folprecht G, Ziemssen T.

Acta Ophthalmol Scand. 2007 Aug;85(5):573-4; author reply 574-5. Epub 2007 Apr 30. No abstract available. PMID: 17474969 [PubMed - indexed for MEDLINE]Related articles

Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.

Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU; Tübingen Bevacizumab Study Group, Schraermeyer U.

Am J Ophthalmol. 2007 Jun;143(6):995-1002. Epub 2007 Apr 23.PMID: 17449002 [PubMed - indexed for MEDLINE]Related articles

Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration--a report of 1 year results.

Lüke M, Ziemssen F, Bartz-Schmidt KU, Gelisken F.

Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1831-6. Epub 2007 Mar 9.PMID: 17347809 [PubMed - indexed for MEDLINE]Related articles

Inner limiting membrane as membranous support in RPE sheet-transplantation.

Beutel J, Greulich L, Lüke M, Ziemssen F, Szurman P, Bartz-Schmidt KU, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1469-73. Epub 2007 Mar 7.PMID: 17342501 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.

Ziemssen F, Voelker M, Altpeter E, Bartz-Schmidt KU, Gelisken F.

Acta Ophthalmol Scand. 2007 Aug;85(5):579-80. Epub 2007 Feb 27. No abstract available. PMID: 17324216 [PubMed - indexed for MEDLINE]Related articles

Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin).

Ziemssen F, Deuter CM, Stuebiger N, Zierhut M.

Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):917-8. Epub 2007 Jan 12. No abstract available. PMID: 17219112 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

Peters S, Julien S, Heiduschka P, Grisanti S, Ziemssen F, Adler M, Schraermeyer U, Bartz-Schmidt KU.

Br J Ophthalmol. 2007 Jun;91(6):827-31. Epub 2006 Dec 19.PMID: 17179166 [PubMed - indexed for MEDLINE]Related articles

Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.

Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU.

Acta Ophthalmol Scand. 2006 Dec;84(6):833-4. No abstract available. PMID: 17083554 [PubMed - indexed for MEDLINE]Related articles

The international intravitreal bevacizumab safety survey.

Ziemssen F, Grisanti S, Bartz-Schmidt KU.

Br J Ophthalmol. 2006 Nov;90(11):1440-1. No abstract available. PMID: 17057183 [PubMed - indexed for MEDLINE]Related articlesFree article

[Multiple sclerosis. An update with practical guidelines for ophthalmologists]

Ziemssen T, Wilhelm H, Ziemssen F.

Ophthalmologe. 2006 Jul;103(7):621-41; quiz 642-3. German. PMID: 16819666 [PubMed - indexed for MEDLINE]Related articles

Intracameral bevacizumab for iris rubeosis.

Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group.

Am J Ophthalmol. 2006 Jul;142(1):158-60.PMID: 16815268 [PubMed - indexed for MEDLINE]Related articles

Does intravitreal injection of bevacizumab have an effect on the blood-aqueus barrier function?

Ziemssen F, Warga M, Neuhann IM, Leitritz M, Biester S, Grisanti S, Bartz-Schmidt KU.

Br J Ophthalmol. 2006 Jul;90(7):922. No abstract available. PMID: 16782958 [PubMed - indexed for MEDLINE]Related articlesFree article

[(Side) effects of VEGF inhibition]

Ziemssen F, Bartz-Schmidt KU, Grisanti S.

Ophthalmologe. 2006 Jun;103(6):484-92. Review. German. PMID: 16763865 [PubMed - indexed for MEDLINE]Related articles

[Early antiexudative response--OCT monitoring after intravitreal bevacizumab injection]

Völcker M, Peters S, Inhoffen W, Ziemssen F.

Ophthalmologe. 2006 Jun;103(6):476-83. Review. German. PMID: 16763864 [PubMed - indexed for MEDLINE]Related articles

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

Jaissle GB, Ziemssen F, Petermeier K, Szurman P, Ladewig M, Gelisken F, Völker M, Holz FG, Bartz-Schmidt KU.

Ophthalmologe. 2006 Jun;103(6):471-5. Review. German. PMID: 16763863 [PubMed - indexed for MEDLINE]Related articles

[Intravitreal bevacizumab for neovascular age-related macular degeneration]

Ladewig MS, Ziemssen F, Jaissle G, Helb HM, Scholl HP, Eter N, Bartz-Schmidt KU, Holz FG.

Ophthalmologe. 2006 Jun;103(6):463-70. Review. German. PMID: 16763862 [PubMed - indexed for MEDLINE]Related articles

Effects of bevacizumab on retinal function in isolated vertebrate retina.

Lüke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T, Lüke C, Partsch M, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group.

Br J Ophthalmol. 2006 Sep;90(9):1178-82. Epub 2006 Jun 5.PMID: 16754646 [PubMed - indexed for MEDLINE]Related articlesFree article

Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.

Petermeier K, Tatar O, Inhoffen W, Völker M, Lafaut BA, Henke-Fahle S, Gelisken F, Ziemssen F, Bopp S, Bartz-Schmidt KU, Grisanti S.

Br J Ophthalmol. 2006 Aug;90(8):1034-9. Epub 2006 Apr 13.PMID: 16613924 [PubMed - indexed for MEDLINE]Related articlesFree article

Secondary unilateral glaucoma and neuroretinitis: atypical manifestation of cat-scratch disease.

Ziemssen F, Bartz-Schmidt KU, Gelisken F.

Jpn J Ophthalmol. 2006 Mar-Apr;50(2):177-9. No abstract available. PMID: 16604397 [PubMed - indexed for MEDLINE]Related articles

Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?

Ziemssen F, Wegner R, Wegner J, Tatar O, Süsskind D, Gelisken F, Rohrbach M, Bartz-Schmidt KU, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1124-31. Epub 2006 Mar 8.PMID: 16523306 [PubMed - indexed for MEDLINE]Related articles